Moderna COVID-19 Vaccine Plant in France Gets Approval

Vials of the Moderna COVID-19 disease vaccine at Recipharm plant, in Monts, central France, on April 22, 2021. Guillaume Souvant/AFP via Getty Images

The European Medicines Agency (EMA) on Friday approved a new manufacturing site in France for the production of Moderna’s COVID-19 vaccine.

The site at Monts will be operated by Recipharm and produce the finished product, the EMA’s committee for human medicines (CHMP) said.